Cellular senescence is a complicated process but here it is explained in a simple infographic. The removal of senescent cells (senolytics) is a very hot topic right now and it represents the arrival of the first of the SENS therapies.
CellAge is one of the companies engaged in senolytic research and they are running a campaign on Lifespan.io if you would like to learn more about them.
https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/
Lilly announced today that CYRAMZA® (ramucirumab) has been approved by the Singapore Health Sciences Authority to treat people with advanced gastric cancer, whose cancer has progressed after prior chemotherapy. First country in ASEAN to approve the new biologic therapy that extends survival in patients with advanced stomach cancer after prior chemotherapy
CYRAMZA® (ramucirumab) is now available to Singaporeans living with advanced gastric cancer. The drug gained approval by Singapore’s Health Science’s Authority (HSA) earlier this year, marking the first regulatory approval in ASEAN. CYRAMZA is already available to patients in Japan, Korea, Taiwan and Hong Kong.
Are you an avid supporter of aging research and a keen longevity activist?
The Biogerontology Research Foundation is offering select summer internships for talented individuals. You’d join a passionate and supportive team in researching diagnostic, prognostic, and therapeutic strategies; advising a panel of investors in developing a roadmap to promote longevity science and related technologies across the globe.
The advertised positions are 3 month internships, with the possibility of continuing afterwards. Free accommodation will be provided for in London, alongside a negotiable salary.
The Biogerontology Research Foundation is a UK based think tank dedicated to aging research and accelerating its application worldwide.
Apply to: [email protected]
Are you an avid supporter of aging research and a keen longevity activist?
The Biogerontology Research Foundation is offering select summer internships for talented individuals. You d join a passionate and supportive team in researching diagnostic, prognostic, and therapeutic strategies; advising a panel of investors in developing a roadmap to promote longevity science and related technologies across the globe.
For the past four decades, the electronics industry has been driven by what is called “Moore’s Law,” which is not a law but more an axiom or observation. Effectively, it suggests that the electronic devices double in speed and capability about every two years. And indeed, every year tech companies come up with new, faster, smarter and better gadgets.
Specifically, Moore’s Law, as articulated by Intel cofounder Gordon Moore, is that “The number of transistors incorporated in a chip will approximately double every 24 months.” Transistors, tiny electrical switches, are the fundamental unit that drives all the electronic gadgets we can think of. As they get smaller, they also get faster and consume less electricity to operate.
In the technology world, one of the biggest questions of the 21st century is: How small can we make transistors? If there is a limit to how tiny they can get, we might reach a point at which we can no longer continue to make smaller, more powerful, more efficient devices. It’s an industry with more than US$200 billion in annual revenue in the U.S. alone. Might it stop growing?
India is all set to test its Agni-V intercontinental ballistic missile (ICBM), capable of striking even the northernmost parts of China, in its final operational configuration from Odisha. Notedly, this will be fourth and the final test of nuclear-capable Agni-V. It will be tested for its full range, before Strategic Forces Command begins its user trials.
The country’s most formidable nuclear missile till now since it brings the whole of China and much more within its strike envelope, the three-stage Agni-V was earlier tested in “an open configuration” in April 2012 and September 2013.
The third test on Jan 30 2015 was done from a hermetically-sealed canister mounted on a Tatra launcher truck in “a deliverable configuration”.
IEEE’s new standards for ethically aligned AI — it’s a start focuses a lot on building ethics/ Morales into AI and not promote the building of autonomous AI Weapons, etc. However, without government & laws on the books this set of standards are a feel good document at best. When it gets into morals, values, not breaking laws, etc. this is when the standard really must come from social and cultural order/ practices, government, and most importantly laws to ensure the standards have the buy in and impact you need. My suggestion to IEEE, please work with gov, tech, legal sys. on this one.
More than 100 experts in artificial intelligence and ethics are attempting to advance public discussion surrounding the ethical considerations of AI.
Now that’s an idea; education for systems. I can see the online university advertisements now showing an autonomous car beeping and flashing its lights over the enjoyment of graduating.
What if I told you to tie your shoes, but you had no laces? Or to cook dinner, but you had no pots or pans.
There are certain tools we need to succeed, which we often don’t have access to or are held back by a gatekeeper.
Dozens of AI / Machine Learning startups experience this same problem because they don’t have enough data to properly train their AI algorithm. Startups that aim to eliminate the error involved in judging cancerous tumors. Startups that aim to improve personalized medicine and create a healthier future.
